ODONTOPREV S.A. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 11.69 BRL | +1.30% |
|
+7.74% | +0.60% |
| Feb. 29 | Transcript : Odontoprev S.A., Q4 2023 Earnings Call, Feb 29, 2024 | |
| Feb. 28 | Odontoprev S.A. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Valuation
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Capitalization 1 | 8,932 | 7,717 | 6,559 | 4,997 | 6,420 | 6,459 | - | - |
| Enterprise Value (EV) 1 | 8,388 | 6,964 | 5,828 | 4,362 | 5,428 | 5,719 | 5,852 | 5,657 |
| P/E ratio | 31.5 x | 21.4 x | 17.5 x | 10.8 x | 12.6 x | 12.1 x | 11.8 x | 11.7 x |
| Yield | 2.08% | 4.32% | 2.85% | - | - | 6.99% | 7.47% | 6.84% |
| Capitalization / Revenue | 4.98 x | 4.37 x | 3.56 x | 2.55 x | 3 x | 2.8 x | 2.62 x | 2.46 x |
| EV / Revenue | 4.67 x | 3.94 x | 3.16 x | 2.22 x | 2.53 x | 2.48 x | 2.38 x | 2.15 x |
| EV / EBITDA | 20 x | 12.8 x | 10 x | 7.57 x | 8.38 x | 8 x | 7.58 x | 6.78 x |
| EV / FCF | 28.2 x | 15.3 x | 13.9 x | 7 x | 17 x | 11.3 x | 12 x | 10.8 x |
| FCF Yield | 3.55% | 6.53% | 7.2% | 14.3% | 5.88% | 8.86% | 8.37% | 9.25% |
| Price to Book | 8.04 x | 6.42 x | 5.81 x | 4.21 x | 4.63 x | 4.34 x | 4 x | - |
| Nbr of stocks (in thousands) | 582,411 | 583,441 | 572,573 | 553,346 | 552,496 | 552,496 | - | - |
| Reference price 2 | 15.34 | 13.23 | 11.45 | 9.030 | 11.62 | 11.69 | 11.69 | 11.69 |
| Announcement Date | 3/5/20 | 3/4/21 | 2/23/22 | 3/2/23 | 2/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Annual data)
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 1,795 | 1,765 | 1,842 | 1,962 | 2,143 | 2,304 | 2,463 | 2,627 |
| EBITDA 1 | 418.5 | 543.5 | 581.1 | 576 | 647.4 | 714.5 | 772.4 | 834.9 |
| EBIT 1 | 397.5 | 518.7 | 523.3 | 538.9 | 591.6 | 659.5 | 715.2 | 770 |
| Operating Margin | 22.14% | 29.38% | 28.4% | 27.47% | 27.61% | 28.62% | 29.03% | 29.31% |
| Earnings before Tax (EBT) 1 | 405.7 | 520 | 547.2 | 646.3 | 724.4 | 740.6 | 798.2 | 872.9 |
| Net income 1 | 284.8 | 361.1 | 380.4 | 452.2 | 511.4 | 528 | 547 | 580.4 |
| Net margin | 15.86% | 20.46% | 20.64% | 23.05% | 23.87% | 22.92% | 22.2% | 22.09% |
| EPS 2 | 0.4871 | 0.6181 | 0.6557 | 0.8385 | 0.9256 | 0.9691 | 0.9918 | 1.000 |
| Free Cash Flow 1 | 297.8 | 454.8 | 419.5 | 623.5 | 319.3 | 506.5 | 489.5 | 523.5 |
| FCF margin | 16.59% | 25.76% | 22.77% | 31.78% | 14.9% | 21.98% | 19.87% | 19.93% |
| FCF Conversion (EBITDA) | 71.16% | 83.68% | 72.2% | 108.25% | 49.32% | 70.89% | 63.38% | 62.7% |
| FCF Conversion (Net income) | 104.57% | 125.94% | 110.3% | 137.88% | 62.44% | 95.93% | 89.5% | 90.2% |
| Dividend per Share 2 | 0.3191 | 0.5711 | 0.3265 | - | - | 0.8167 | 0.8736 | 0.8000 |
| Announcement Date | 3/5/20 | 3/4/21 | 2/23/22 | 3/2/23 | 2/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
Income Statement Evolution (Quarterly data)
| Fiscal Period: December | 2021 Q3 | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Net sales 1 | 467.1 | 469.4 | 471.5 | 481 | 495.4 | 513.7 | 523.8 | 527.7 | 546 | 545.2 | 556.5 | 555.8 | 565.9 | 571.3 |
| EBITDA 1 | 144.7 | 139.8 | 166.3 | 143.5 | 137.7 | 128.5 | 202 | 147.5 | 156.2 | 141.6 | 200.4 | - | - | - |
| EBIT 1 | 137.2 | 102.7 | 160.6 | 133.1 | 127.8 | 117.4 | 190.5 | 135 | 133.5 | 124.6 | 196.3 | 125.5 | 78.63 | 221.9 |
| Operating Margin | 29.37% | 21.88% | 34.05% | 27.68% | 25.8% | 22.86% | 36.37% | 25.57% | 24.46% | 22.85% | 35.28% | 22.58% | 13.9% | 38.85% |
| Earnings before Tax (EBT) | - | - | 234.1 | 147.8 | 130.4 | 134 | 246.2 | - | - | 164.4 | - | - | - | - |
| Net income 1 | 97.8 | 87.18 | 161.5 | 99.57 | 96.19 | 94.95 | 169.6 | 117.2 | 123.4 | 114.6 | 156.5 | - | - | - |
| Net margin | 20.94% | 18.57% | 34.24% | 20.7% | 19.42% | 18.48% | 32.39% | 22.22% | 22.6% | 21.02% | 28.11% | - | - | - |
| EPS 2 | 0.1727 | 0.1517 | 0.3135 | 0.1790 | 0.1740 | 0.1720 | 0.3070 | 0.2120 | 0.2230 | 0.2074 | 0.3000 | - | - | - |
| Dividend per Share | 0.0236 | 0.0928 | 0.1357 | - | 0.0317 | - | - | - | - | - | - | - | - | - |
| Announcement Date | 10/27/21 | 2/23/22 | 4/27/22 | 7/27/22 | 10/26/22 | 3/2/23 | 5/11/23 | 8/9/23 | 11/9/23 | 2/28/24 | - | - | - | - |
1BRL in Million2BRL
Estimates
Balance Sheet Analysis
| Fiscal Period: December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|
| Net Debt 1 | - | - | - | - | - | - | - | - |
| Net Cash position 1 | 544 | 753 | 731 | 634 | 992 | 740 | 607 | 802 |
| Leverage (Debt/EBITDA) | - | - | - | - | - | - | - | - |
| Free Cash Flow 1 | 298 | 455 | 420 | 623 | 319 | 507 | 490 | 524 |
| ROE (net income / shareholders' equity) | 26.6% | 31.2% | 32.8% | 39.3% | 40.7% | 33.1% | 34.1% | 33.9% |
| ROA (Net income/ Total Assets) | 16.7% | 19.6% | 19.7% | 22.9% | 25.3% | 20.8% | 20.4% | - |
| Assets 1 | 1,708 | 1,845 | 1,927 | 1,977 | 2,018 | 2,542 | 2,688 | - |
| Book Value Per Share 2 | 1.910 | 2.060 | 1.970 | 2.140 | 2.510 | 2.700 | 2.920 | - |
| Cash Flow per Share 2 | 0.5100 | 0.5200 | 0.8100 | 1.260 | 0.7500 | 1.260 | - | - |
| Capex 1 | 11 | 35.3 | 52 | 71.4 | 95.3 | 94 | 93.5 | 93.5 |
| Capex / Sales | 0.61% | 2% | 2.82% | 3.64% | 4.45% | 4.08% | 3.8% | 3.56% |
| Announcement Date | 3/5/20 | 3/4/21 | 2/23/22 | 3/2/23 | 2/28/24 | - | - | - |
1BRL in Million2BRL
Estimates
EPS & Dividend
Year-on-year evolution of the PER
Year-on-year evolution of the Yield
Change in Enterprise Value/EBITDA
Trading Rating
Investor Rating
ESG Refinitiv
B
Sell
Buy
Mean consensus
HOLD
Number of Analysts
10
Last Close Price
11.69
BRL
Average target price
12.8
BRL
Spread / Average Target
+9.50%
EPS Revisions
| 1st Jan change | Capi. | |
|---|---|---|
| +0.60% | 1.26B | |
| -15.06% | 5.53B |
- Stock Market
- Equities
- ODPV3 Stock
- Financials Odontoprev S.A.
